PSYENCE BIOMEDICAL LTD.
For the period ended Sep 14, 2026. Filed Sep 14, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Sep 14, 2026 · Filed Sep 14, 2026
Use the contents to explore the available documents and sections.
PBM$2.96+0.7%Stored close · as of Nov 6, 2026
Contents
EXPLANATORY NOTE
On September 14, 2026, the Company issued a press release titled “Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development.”
A copy of this press release is furnished as Exhibit 99.1 to this Form 6-K and is incorporated herein by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.